My name is Tess Fries and here’s my story.
It’s simple.
I wasn’t trained in a lab or raised in academia.
I don’t have a white lab coat, a title, a published paper,
or an academic track record.
Elixira is my track record.
I designed Elixira backwards — from the vision, from the outcome.
From a world without cancer.
Then I traced every part back to today’s technology,
until it could be built today.
I didn’t think outside the box — there was no box.
Elixira was built by connecting fields usually studied in isolation
— nanotechnology, AI, energy harvesting, and oncology.
Where others saw separation, I saw synergy.
Where others saw pieces, I saw a whole.
Everything that Elixira is already exists
as separate validated peer-reviewed technologies.
I’m just a woman who invented a system designed to prevent cancer.
I’m 33, my mother’s a nurse and my father’s a doctor.
I grew up knowing that early detection and decisive action
can mean the difference between life and death.
That understanding lives at the core of Elixira.
About ten years ago, a stranger told me that a technology
using nanobots to cure cancer already existed
— but never reached the public.
I never forgot that.
So time passed. Life moved on.
But the cure never came.
So in 2025, I built Elixira — a fully formed platform based on
existing technologies, validated as early as 2020.
An extension and elevation of existing treatments.
The day after I filed the patent, someone very close to me told me
they found something on her mammogram.
It was cancer.
So to me, Elixira is more than a technology.
It’s more than a world shift.
It’s personal.
I can’t imagine doing something more meaningful than Elixira.
Because we all deserve a world free from cancer.
And for this mission, I am eternally grateful.
